Scholarlink

In May 2023, JapanJapan downgraded the legal status of coronavirus disease 2019 (COVID-19) from Class 2 to Class 5Class 5, placing it in the same class as common infectious diseasesDiseases. This chapter provides an overview of Japan’s medical system after reclassifying COVID-19COVID-19 as Class 5, including changes in subsidies for dispatching healthcareHealthcare workers and public financial support. Drawing on lessons learned from the COVID-19Pandemic pandemicCOVID-19 pandemic, this chapter explores Japan’s internal health strategyInternal health strategy and how it aims to transform universal health coverage (UHC)Universal Health Coverage (UHC) into a global healthGlobal health strategy with two critical policy goals: establishing a global health architectureGlobal health architecture and promoting sustainable UHC in JapanJapan and abroad in the post-COVIDPost-COVID-19-19 era.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Japan’s Internal–External Health Strategy in the Post-COVID-19 Era

  • 章节

  • 发表日期：

    2025年

查看全文
  • Ai Tashiro

摘要

In May 2023, JapanJapan downgraded the legal status of coronavirus disease 2019 (COVID-19) from Class 2 to Class 5Class 5, placing it in the same class as common infectious diseasesDiseases. This chapter provides an overview of Japan’s medical system after reclassifying COVID-19COVID-19 as Class 5, including changes in subsidies for dispatching healthcareHealthcare workers and public financial support. Drawing on lessons learned from the COVID-19Pandemic pandemicCOVID-19 pandemic, this chapter explores Japan’s internal health strategyInternal health strategy and how it aims to transform universal health coverage (UHC)Universal Health Coverage (UHC) into a global healthGlobal health strategy with two critical policy goals: establishing a global health architectureGlobal health architecture and promoting sustainable UHC in JapanJapan and abroad in the post-COVIDPost-COVID-19-19 era.